Dozens of mosquitoes test positive for West Nile Virus in Lehigh Co
E-cigarette vapour tied to changes in lung cells
No honor roll for DC-area hospitals in annual US News rankings
New Haven police make arrest after dozens of overdoses
Health officials continuing to monitor measles outbreak
This US postal stamp helped fund key breast cancer study
05 June 2018, 07:42 | Melissa Porter
Getty Images Canopy
Sparano concluded that in women with HR-positive, HER2-negative, AN-negative breast cancer who had a RS of 11 to 25, adjuvant ET was not inferior to CET in the ITT analysis.
Dr. Otis Brawley, chief medical and scientific officer for the American Cancer Society said that he was "delighted" by the study and anxious about unnecessary cancer treatment and the side effects that come from chemotherapy.
According to the American Cancer Society, one in eight women will develop breast cancer in her life. "The study showed that if you take the group as a whole, there is no difference in the risk of recurrence when you compare chemotherapy to no chemotherapy".
However, certain women 50 or younger will still benefit from having chemotherapy.
Sunday's results came from a federally sponsored trial called TailorX, which was created to help doctors more precisely tailor treatments for early-stage breast cancer.
Dr. Lisa Carey, a breast specialist at the University of North Carolina's Lineberger Comprehensive Cancer Center, said she would be very comfortable advising patients to skip chemo if they were like those in the study who did not benefit from it.
With women hardest hit by migraine headaches, Swiss drugmaker Novartis is gearing up its marketing message to counteract sexism that it worries might become a barrier to adoption of its new medicine Aimovig.
The results show that all women over 50 with a recurrence score of 0 to 25 can be spared chemotherapy and its toxic side effects. Since 2006, the trial has enrolled more than 10,000 women in the United States and five other countries diagnosed with early breast cancer and followed their progress through post-surgery treatment.
The study is limited in some ways. A key part - the initial $4.5 million of the cancer institute's $36 million contribution - came from the stamp, said Dinah Singer, who is involved in the institute's use of stamp proceeds.
Researchers say many women with early-stage breast cancer might not need chemotherapy.
They found these women may benefit from surgery and hormone therapy and may not have to go through chemotherapy treatments.
A high recurrence score, above 25, means chemo is advised to ward off a recurrence, while a low score, below 10, means it is not. Others want chemo for even the smallest chance of benefit.
But doctors have been unsure how to treat women with scores in the intermediate range of 11 and 25.
"I don't ever think I'll ever have the feeling that I'm completely out of the woods, but this definitely is exciting and makes me feel good", Mall said.
Researchers at the National Cancer Institute have put a patient with metastatic breast cancer into complete remission by using a new approach to immunotherapy.
"A lot of work needs to be done, but the potential exists for a paradigm shift in cancer therapy - a unique drug for every cancer patient", he said.
Breast Cancer Now also called for Nice to reflect the findings in its guidance. "We want to give the right amount", he said.
‘Solo’ still No. 1 but drops 65 percent in 2nd weekend
The survival tale is based on a true story and scored 67 percent positive reviews, according to aggregator Rotten Tomatoes. In its sixth week out, Disney's Avengers: Infinity War performed well, pulling in US$10.4 million for fourth place.
Johnny Depp Stops to Sign Autographs for Fans in Germany
Fans have also taken to Instagram to suggest that the frail look could be for his most recent role in Richard Says Goodbye . Depp is now touring around Europe with the band, which includes rock legends Alice Cooper and Joe Perry (from Aerosmith ).
May tackles Trump over steel tariffs
Freeland's comments on the tariffs mirror remarks Prime Minister Justin Trudeau made on NBC's "Meet the Press" earlier on Sunday. Trudeau said he would seek out Trump at the meeting of the G-7 leaders this week in Quebec to discuss trade issues.
Arsenal In Shock Link With Manchester United Star
Arsenal are big favourites with the bookies to secure Fellaini's signature, however there are plenty of teams in the running. Naturally, the rumours of Fellaini heading to the Emirates had fans of both United and Arsenal reacting on social media.